Original paper
Development of fever following first administration of�zoledronate as a prognostic factor in advanced non‑small cell lung cancer patients with bone metastases
Abstract
Nitrogen‑containing bisphosphonates (N‑BPs), which are usually used for the treatment of advanced cancer with bone metastasis, occasionally cause fever following the first administration. However, it is unclear as to how the development of fever following the first administration of N‑BP is associated with clinical outcome. The aim of the present study was to determine the prognostic value of the development of fever following the first...
Paper Details
Title
Development of fever following first administration of�zoledronate as a prognostic factor in advanced non‑small cell lung cancer patients with bone metastases
Published Date
Oct 10, 2017
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History